Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015
2008 ◽
Vol 19
(5)
◽
pp. 920-926
◽
C.-H. Köhne
◽
J. De Greve
◽
J.T. Hartmann
◽
I. Lang
◽
P. Vergauwe
◽
...
2008 ◽
Vol 26
(15_suppl)
◽
pp. 15064-15064
H. Albrecht
◽
A. Wein
◽
K. Wolff
◽
V. Brueckl
◽
C. Meier
◽
...
H Albrecht
◽
A Wein
◽
C Meier
◽
N Ostermeier
◽
V Brueckl
◽
...
2005 ◽
Vol 23
(16_suppl)
◽
pp. 3516-3516
◽
A. Schalhorn
◽
F. W. Ludwig
◽
D. Quietzsch
◽
P. A. Maubach
◽
G. Schlimok
◽
...
2016 ◽
Vol 27
(7)
◽
pp. 1273-1279
◽
G. Folprecht
◽
C. Pericay
◽
M.P. Saunders
◽
A. Thomas
◽
R. Lopez Lopez
◽
...
2006 ◽
Vol 94
(6)
◽
pp. 798-805
◽
J Souglakos
◽
N Androulakis
◽
K Syrigos
◽
A Polyzos
◽
N Ziras
◽
...
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3738-3738
M. Pirovano
◽
A. Quintè
◽
S. Masseroni
◽
A. Romanelli
◽
A. Biffi
◽
...
2005 ◽
Vol 23
(16_suppl)
◽
pp. 3507-3507
◽
H.-T. Arkenau
◽
H. Schmoll
◽
S. Kubicka
◽
A. Kretzschmar
◽
W. Freier
◽
...
2007 ◽
Vol 93
(6)
◽
pp. 557-561
Nicla La Verde
◽
Marina Garassino
◽
Claudia Bareggi
◽
Paola Sburlati
◽
Karen Borgonovo
◽
...
Close
Export Citation Format
Close
Share Document
Close